% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • investormdpart2 investormdpart2 Mar 26, 2012 5:56 PM Flag

    Are they serious going into a Phase 2 trial with this data?

    I suppose I'm just ready for Abbott to scoop this up and to count all the cash on the balance sheet. CNS is always full of disasters. At least, TD is a novel indication and under served.

    I think everyone was expecting really good data because small trials are easy to control. My disappointment is really that it wasn't well done. In a larger trial this would cost a fortune so I just hope they work out the issues.

43.37-0.3100(-0.71%)Apr 24 4:00 PMEDT